BioMarin Pharmaceutical Inc. To Join The NASDAQ-100 Index Beginning July 27, 2015

Date 23/07/2015

Nasdaq (Nasdaq:NDAQ) today announced that BioMarin Pharmaceutical Inc. (Nasdaq:BMRN), will become a component of the NASDAQ-100 Index® (Nasdaq:NDX), the NASDAQ-100 Equal Weighted Index (Nasdaq:NDXE) and the NASDAQ-100 Ex-Technology Index (Nasdaq:NDXX) prior to market open on Monday, July 27, 2015. BioMarin Pharmaceutical Inc. will replace DIRECTV (Nasdaq:DTV).

BioMarin Pharmaceutical Inc. is headquartered in Novato, California, and has a market capitalization of approximately $22.7 billion. For more information about the company, go to www.bmrn.com.